## Brief (high-level only)

- This file gives a short checklist of common regulatory-relevant assays and guidelines to consider during lead optimisation. It is NOT legal or regulatory advice.

## Common regulatory checks (discovery â†” preclinical)

- Genotoxicity: Ames test and follow-up mutagenicity testing where indicated.

- Cardiac safety: hERG liability screening as an early flag for QT risk.

- Pharmacokinetics & DDI: CYP inhibition/induction assays and Caco-2/permeability testing.

- ICH references: consult ICH guidance documents and local regulations for formal development plans.